| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
PET Department, Division of Medical Imaging Services, Royal Prince Alfred Hospital, Sydney, Australia
Correspondence: For correspondence or reprints contact: Michael J. Fulham, MD, PET Department, Royal Prince Alfred Hospital, Missenden Road, Camperdown 2050, Sydney, Australia.
ABSTRACT
Accurate estimation of local cerebral metabolic rate of glucose utilization (LCMRGlu) with PET requires a separate measurement of photon attenuation using a transmission source that extends study duration. The feasibility of postinjection transmission (PIT) scanning has been demonstrated but not previously validated in humans. Methods: Preinjection and postinjection transmission scans were performed in 26 patients undergoing routine [18F]fluorodeoxyglucose (FDG) neurological PET. The PIT data were processed with two methods: One estimated emission contamination using an independent emission scan (PITind); the other estimated the contamination directly from the PIT scan, using simultaneously acquired emission data for subtraction (PITsim). These methods were compared with measured attenuation correction (AC) using preinjection transmission data (ACpre) and calculated AC (ACcalc). After reconstruction, image data were reformatted to fit a standard brain atlas to facilitate analysis of the region of interest and to allow subtraction of datasets averaged over all subjects. Results: The ratios of LCMRGlu values with respect to those obtained by the ACpre method ranged from 0.98 to 1.06 (mean ± s.d., 1.01 ± 0.02) for PITind, from 0.96 to 1.04 (mean 0.99 ± 0.02) for PITsim and from 0.77 to 1.12 (mean 0.96 ± 0.07) for ACcalc. Both PIT methods agreed well with the ACpre method, whereas ACcalc gave rise to appreciable bias in structures near thick bone or sinuses. Conclusion: Accurate quantitative estimates of LCMRGlu can be obtained using PIT measurements. The PIT methods shorten study duration and increase patient throughput. The PITsim method has the further advantage that it is not affected by tracer redistribution and can therefore be applied to tracers with relatively rapid kinetics in vivo.
Key Words: postinjection transmission • neurology • fluorine-18-fluorodeoxyglucose • PET • attenuation correction
This article has been cited by other articles:
|
|
 |
|
  D. von Borczyskowski, U. Schulte, W. Brenner, M. Clausen, and R. Buchert Occurrence of an Artifact in Brain 18F-FDG PET with Calculated Attenuation Correction J. Nucl. Med. Technol., December 1, 2006; 34(4): 232 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. van der Weerdt, R. Boellaard, P. Knaapen, C. A. Visser, A. A. Lammertsma, and F. C. Visser Postinjection Transmission Scanning in Myocardial 18F-FDG PET Studies Using Both Filtered Backprojection and Iterative Reconstruction J. Nucl. Med., February 1, 2004; 45(2): 169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zaidi and B. Hasegawa Determination of the Attenuation Map in Emission Tomography J. Nucl. Med., February 1, 2003; 44(2): 291 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.F. Vansteenkiste Imaging in lung cancer: positron emission tomography scan Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
